Magnetic resonance guidance of percutaneous ethanol injection in liver

A preliminary analysis and model of prostate injection distributions

PURPOSE

Understanding the internal dynamics of prostate injections, particularly injection pattern distribution is a key step to developing new therapies for prostate disease that may be best served with a direct injection approach. Due to excellent properties involving liquid contrast agents, MRI can be used for targeting and monitoring of injections into organs and tissues.

MATERIALS AND METHODS

Eleven intraprostatic injections were performed in vivo with canines using a custom transrectal guiding and imaging system for use in a standard 1.5 T MR scanner. In addition, 25 injections were performed on excised cadaveric human prostates, using a MedRad Spectris injector system. MRI was used to guide the injections and monitor intraparenchymal injection distribution.

RESULTS

T1 and T2-weighted MR images were correlated with histology to produce three-dimensional data sets that can be used to analyze trends in injection patterns. This analysis was used to develop strategies for injection prediction such as gadolinium pre-injections and diffusion-weighted imaging guidance. In addition, a rough model of prostate injections is described, and a preliminary injection guide is developed that takes into account the individual clinician's goals for therapy.

CONCLUSIONS

MR visualization of injected therapeutic agents allows for prediction and monitoring of drug distributions, possibly improving efficacy and reducing side effects. Injection analysis and modeling may be used to assist in optimizing clinical treatments that require or would benefit from focal parenchymal injections into the prostate.

Contrast Material–enhanced Visualization of the Ablation Medium for Magnetic Resonance– monitored Ethanol Injection Therapy: Imaging and Safety Aspects

PURPOSE

This study was performed to test whether the dissociation rate of free Gd3+ ions from gadoterate meglumine is significantly increased when the contrast agent is dissolved in ethanol and whether the magnetic resonance (MR) signal of gadolinium/ethanol solutions is enhanced to a degree that promises reliable detection during MR imaging-guided intralesional administration, such as for the treatment of low-flow venous malformations.

MATERIALS AND METHODS

The apparent gadoterate meglumine-induced enhancement of the longitudinal proton relaxation rate of sterile ethanol/water solutions, stored at a temperature of 24 degrees C +/- 5 degrees C in the dark, was monitored for 2 weeks. The content of dissociated Gd3+ ions was determined after 6 and 8.5 months of storage. The signal difference between contrast agent/ethanol solutions and muscle tissue was assessed with imaging at 0.5 T and 1.5 T.

RESULTS

Commercialized gadoterate meglumine diluted with 94% ethanol was not shown to have released toxic Gd3+ during storage times that exceed its physiologic circulation and excretion times after intravenous injection by a factor of more than 100. A maximum dissociation rate of 0.05% per month was estimated from the detection limit of the analysis. The apparent molar relaxivity of the contrast agent in the mixtures varied by less than 0.1 L/mmol per second with no temporal trend. Gradient-echo ethanol/muscle contrast increased with Gd concentrations to maximums of 15 mmol/L (at 0.5 T) and 25 mmol/L (at 1.5 T).

CONCLUSIONS

Neither limited solubility nor release of Gd3+ ions could be identified as a general safety hazard associated with the application of gadoterate meglumine/ethanol solutions at Gd concentrations of 0.5-25 mmol/L, and such ablation mixtures could be efficiently and reliably visualized.

MR appearance and spectral features of injected ethanol in the liver: implication for fast MR-guided percutaneous ethanol injection therapy

PURPOSE

Our goal was to evaluate several fast MR strategies for monitoring ethanol distributions so that percutaneous ethanol injection might be guided with MRI.

METHOD

Fast RF spoiled GRE sequences (SPGR) and T2-weighted rapid acquisition with relaxation enhancement (RARE) sequences with and without spectroscopic-quality water suppression techniques were assessed for their ability to depict the distribution of injected ethanol in ex vivo pig liver. A line scan Carr-Purcell-Meiboom-Gill spectroscopic imaging sequence was used to validate observations and measure spectral relaxation characteristics of the ethanol signal in liver. Injected deuterated ethanol was also tested as an alternative possibility to depict the distribution of ethanol.

RESULTS

The water-suppressed T2-weighted RARE sequence depicted the distribution of ethanol better than other sequences. Deuterated ethanol appeared as a signal void on all sequences.

CONCLUSION

Water-suppressed T2-weighted RARE sequences could be useful to rapidly monitor MR-guided PEI.